ClinicalTrials.gg
Sign In

Drug

NI-0101 clinical trials

studies test it
3
open now
2
in phase 3
0
first study started
2017

Keep track of what changes. Save the NI-0101 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Cohort B: paridiprubart
2

Development codes

NI-0101
1

Studies by the year they started

3 studies that test it; most in 2025 (2)

Studies that test NI-0101, by start year
YearStudies
20171
20252

By phase

A phase 1/2 study counts in both.

Phase 2
3

What it is tested for

Each study’s main condition, where its own words name it.

Respiratory Distress Syndrome
2
Arthritis, Rheumatoid
1

Who runs them

Industry 3 · Other 0

PPD Development, LP (2) · Light Chain Bioscience - Novimmune SA (1)

Often tested with

Tested in the same studies.

Vilobelimab (1) · Bevacizumab (1)

Studies

Open first, then newest update. How each study uses NI-0101 is read from its arms, and is right about nine times in ten.

Testing it · 3